Literature DB >> 3821928

Spinal facilitation in cholinergic-sympathetic efferents by desipramine.

A Walland.   

Abstract

Electrodermal potentials (EDPs) evoked by electrical stimulation of the cholinergic-sympathetic system at different levels were recorded in the forepaws of anaesthetized cats and used as a measure of sudomotor activity. After pretreatment with yohimbine (0.25 mg/kg i.v.) to block alpha 2-adrenoceptors, unilateral electrical stimulation of the hypothalamus (square wave pulses 1 ms duration, 16 Hz, 2 s train length at intervals of 1 min) induced EDPs in both forepaws. Injection of the inhibitor of neuronal catecholamine reuptake, desipramine (1 mg/kg i.v.), facilitated the EDPs in both forepaws, even though access of the drug to the sweat glands was prevented by application of a tourniquet to one paw. The facilitation was abolished by injection of the specific alpha 1-adrenoceptor antagonist, prazosin (0.5 mg/kg i.v.). An equal enhancement of this effect by desipramine (1 mg/kg i.v.) and its abolition by prazosin (0.5 mg/kg i.v.) was obtained in cats with the brain stem transected at the level of the medulla oblongata and electrical stimulation of the spinal cord at C1. EDPs evoked in the right forepaw by preganglionic electrical stimulation of the right stellate ganglion were inhibited by desipramine (1 mg/kg i.v.). From these and previous results it is concluded that inhibition of neuronal reuptake of catecholamines results in facilitation of activity in sudomotor efferents. This effect is mediated by spinal alpha 1-adrenoceptors and provides an explanation of the occasional occurrence of excessive sweating in psychiatric patients treated with tricyclic antidepressants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3821928     DOI: 10.1007/bf00569369

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

Review 1.  CLINICAL PHARMACOLOGY OF IMIPRAMINE AND RELATED ANTIDEPRESSANT COMPOUNDS.

Authors:  G L KLERMAN; J O COLE
Journal:  Pharmacol Rev       Date:  1965-06       Impact factor: 25.468

2.  The electrodermal response as a model for central sympathetic reactivity: the action of clonidine.

Authors:  M C Koss; M A Davison
Journal:  Eur J Pharmacol       Date:  1976-05       Impact factor: 4.432

3.  Tricyclic antidepressant drugs block histamine H2 receptor in brain.

Authors:  J P Green; S Maayani
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

Review 4.  Central alpha-adrenergic systems as targets for hypotensive drugs.

Authors: 
Journal:  Rev Physiol Biochem Pharmacol       Date:  1978       Impact factor: 5.545

5.  Skin potential response and sweat output of the cat foot pad.

Authors:  T Morimoto; Y Imai; H Watari
Journal:  Jpn J Physiol       Date:  1974-04

6.  Brain histamine receptors as targets for antidepressant drugs.

Authors:  P D Kanof; P Greengard
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

7.  Permissive role of spinal alpha 1-adrenoceptors in sudomotor efferents.

Authors:  M C Rybarczyk; A Walland
Journal:  Eur J Pharmacol       Date:  1985-06-19       Impact factor: 4.432

8.  Clonidine inhibits nicotinic effects in ganglia of the cholinergic-sympathetic system.

Authors:  A Walland
Journal:  Eur J Pharmacol       Date:  1984-06-15       Impact factor: 4.432

9.  Clonidine inhibits electrodermal potentials induced by preganglionic stimulation.

Authors:  A Walland
Journal:  Eur J Pharmacol       Date:  1984-06-15       Impact factor: 4.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.